Internal Memo to Members of Operations Committee re Blood Products Advisory Committee Meeting December 15 and 16, 1983. Discusses FDA requests for different blood collection, screening procedures and the suggestion that applying anti-core Hepatitis B testing and heat treatment could possibly provide a safe Factor VIII product. Proposal made to set up a task force to examine costs and logistics of implementing anti-core Hepatitis B screening.